Antidepressants - SSRIs and SNRIs: Nursing pharmacology

2,342views

Antidepressants - SSRIs and SNRIs: Nursing pharmacology

Pharm

Pharm

Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Antiglaucoma medications: Nursing pharmacology
Geriatric considerations - Medications: Nursing
Substance use disorder - Medications and illicit drugs: Nursing
Medications to control airway secretions: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Using an inhaler: Information for patients and families
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Biologic agents: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Glaucoma: Nursing process (ADPIE)
Geriatric considerations - Respiratory: Nursing
Antihyperlipidemics - Statins: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Medication labels: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Medication administration - Insulin: Nursing pharmacology
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Insulin: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Case study - Wound infection: Nursing
Medication administration - Heparin: Nursing pharmacology
Case study - Healthcare-associated infection (HAI): Nursing
Antibiotics - Fluoroquinolones: Nursing pharmacology
Stimulant medications for attention-deficit hyperactivity disorder (ADHD): Nursing pharmacology
Medication orders: Nursing pharmacology
Medication administration - Safety principles: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Pharmacodynamics: Nursing pharmacology
Analgesics: Nursing pharmacology
Mood stabilizers: Nursing pharmacology
Antipsychotics: Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Antiemetics: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Ergot alkaloids: Nursing pharmacology
Antibiotics - Penicillins: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antacids: Nursing pharmacology
Antihistamines: Nursing pharmacology
Laxatives: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Iron preparations: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Nitrates: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Vaccines: Nursing pharmacology
Electrolyte balance - Overview: Nursing
Arterial blood gas (ABG) - Respiratory acidosis: Nursing
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology

Notes

ANTIDEPRESSANTS: SSRIs, SNRIs
DRUG NAME
fluoxetine (Prozac), fluvoxamine (Luvox), sertraline (Zoloft), paroxetine (Paxil, Pexeva), citalopram (Celexa), escitalopram (Lexapro)
duloxetine (Cymbalta), venlafaxine (Effexor), desvenlafaxine (Pristiq), levomilnacipran (Fetzima)
CLASS
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin-norepinephrine reuptake inhibitors (SNRIs)
MECHANISM OF ACTION
Inhibit serotonin reuptake, increasing its concentration in the synaptic cleft
Inhibit serotonin and norepinephrine reuptake, increasing their concentration in the synaptic cleft
INDICATIONS
  • Major depressive disorder
  • Anxiety disorders (obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, phobias)
  • Phobias
  • Major depressive disorder
  • Generalized anxiety disorder
  • Neuropathic pain
ROUTE(S) OF ADMINISTRATION
PO
SIDE EFFECTS
  • Anxiety
  • Nervousness
  • Agitation
  • Dizziness
  • Drowsiness
  • Insomnia
  • Loss of appetite
  • Nausea
  • Vomiting
  • Diarrhea
  • Sexual dysfunction
  • Headache
  • Sweating
  • Hyponatremia
  • Dry mouth
  • Bruxism
  • Serotonin syndrome
  • Boxed warning: suicidal thinking in children, adolescents, and young adults
  • SNRIs: hypertension, tachycardia, closed-angle glaucoma, urinary retention
CONTRAINDICATIONS AND CAUTIONS
  • Combination with MAOIs
  • QT prolongation or myocardial infarction
  • Pregnancy
  • Renal or hepatic disease
  • Diabetes
  • Glaucoma
  • Severely depressed clients with suicidal thinking
NURSING CONSIDERATIONS
Assessment and monitoring: SSRIs and SNRIs
  • Baseline assessment of depressive symptoms; continue during antidepressant therapy
  • Monitor for suicidal thoughts, especially during the first few weeks
  • Baseline mental status, vital signs, weight, serum electrolytes, kidney and liver function
  • Pregnancy status

Client education: SSRIs and SNRIs
  • Therapeutic effects can take 1–3 weeks
  • Take medication exactly as prescribed
  • Report any changes in symptoms or suicidal thoughts to health care provider
  • Administer medication in the morning
  • Avoid hazardous activities with fatigue and dizziness
  • Notify healthcare provider about adverse effects
    • SNRIs: Void before taking this medication
  • Never abruptly stop medication therapy
Author: Victoria S. Recalde, MD
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Antidepressants are medications primarily used to treat major depressive disorder, which is a condition associated with a persistent feeling of sadness and loss of interest in everyday activities.

Even though the exact cause of major depressive disorder is still unknown, there's some evidence that suggests that it’s related to low levels of neurotransmitters called monoamines, which include serotonin, norepinephrine, and dopamine.

In this video, we’re going to cover two of the main classes of antidepressants: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors.

First, let’s focus on selective serotonin reuptake inhibitors, or SSRIs for short, such as fluoxetine, fluvoxamine, sertraline, paroxetine, citalopram, and escitalopram.

SSRIs are taken orally, and once absorbed into the bloodstream, they travel to the brain. Here, SSRIs inhibit the reuptake of serotonin.

As a result, free levels of serotonin within the synaptic cleft are increased right away, although the effect of SSRIs alleviating symptoms of depression are not evident for a few weeks.

Other indications for SSRIs include anxiety disorders like obsessive-compulsive disorder, or OCD; post traumatic stress disorder, or PTSD; panic disorder and phobias; as well as eating disorders like bulimia.

On the other hand, serotonin-norepinephrine reuptake inhibitors, or SNRIs, include duloxetine, venlafaxine, desvenlafaxine, and levomilnacipran.

SNRIs are also taken orally, and once they reach the brain, they inhibit the reuptake of both serotonin and norepinephrine, increasing their levels in the synaptic cleft.

Other indications for SNRIs besides major depressive disorder include generalized anxiety disorder and neuropathic pain.

Now, the brain has different types of serotonin receptors besides the ones involved in depression. Some of them mediate functions like mood, sleep, appetite, or sexual function.

So, some side effects of SSRIs and SNRIs include anxiety or nervousness, agitation, insomnia or drowsiness, loss of appetite, and sexual dysfunction.

Other side effects include headache, dizziness, sweating, and hyponatremia, as well as bruxism, dry mouth, nausea, vomiting, and diarrhea.

Additionally, SSRIs and SNRIs can also cause serotonin syndrome, which usually occurs when these medications are combined with other antidepressants that increase the level of serotonin in the brain, especially monoamine oxidase inhibitors, or MAOIs for short.

Clients that develop serotonin syndrome typically present with skin flushing, hyperthermia, agitation, muscle rigidity, seizures, and altered mental status or even coma.

Now, SNRIs also increase the levels of norepinephrine, so they can cause side effects like hypertension and tachycardia, as well as closed-angle glaucoma, and urinary retention.

Finally, an important boxed warning for all antidepressants is that they may increase the risk of suicidal thinking in children, adolescents, and young adults.

Sources

  1. "Focus on Nursing Pharmacology" LWW (2019)
  2. "Pharmacology" Elsevier Health Sciences (2014)
  3. "Mosby's 2021 Nursing Drug Reference" Mosby (2020)
  4. "Saunders Comprehensive Review for the NCLEX-RN Examination" Saunders (2016)
  5. "SSRI Antidepressant Medications" The Primary Care Companion to The Journal of Clinical Psychiatry (2001)